GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CXW · Dec 31, 2017

CoreCivic, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001564590-18-002898Reit
Operating-cash-flow growth21thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

-9.07% · OPTIONAL · VALID

Debt83thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_debt

$1.4B · CORE · VALID

Net-income growth29thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.net_income

-19.04% · CORE · VALID

Cash and equivalents50thOwn-history percentile · N=18
Evidence method

Level · gp.fundamentals.cash

$52.2M · CORE · VALID

Operating-income growth14thOwn-history percentile · N=14
Evidence method

Yoy · gp.fundamentals.operating_income

-12.15% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History49 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-7.41%
Current
-9.07%
Delta
-1.66%
Debt Increased
Previous
$1.4B
Current
$1.4B
Delta
$26.0M
Earnings Growth Increased
Previous
-25.59%
Current
-19.04%
Delta
6.55%
Liquidity Increased
Previous
$42.7M
Current
$52.2M
Delta
$9.4M
Profitability Increased
Previous
-17.77%
Current
-12.15%
Delta
5.61%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.